Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Lindestam Arlehamn CS, Pham J, Alcalay RN, Frazier A, Shorr E, Carpenter C, Sidney J, Dhanwani R, Agin-Liebes J, Garretti F, Amara AW, Standaert DG, Phillips EJ, Mallal SA, Peters B, Sulzer D, Sette A.

J Immunol. 2019 May 13. pii: ji1801506. doi: 10.4049/jimmunol.1801506. [Epub ahead of print]


Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

Chahine LM, Iranzo A, Fernández-Arcos A, Simuni T, Seedorff N, Caspell-Garcia C, Amara AW, Comella C, Högl B, Hamilton J, Marek K, Mayer G, Mollenhauer B, Postuma R, Tolosa E, Trenkwalder C, Videnovic A, Oertel W; PPMI Sleep Working Group.

NPJ Parkinsons Dis. 2019 Jan 29;5:2. doi: 10.1038/s41531-018-0073-1. eCollection 2019.


Self-reported physical activity levels and clinical progression in early Parkinson's disease.

Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T; Parkinson's Progression Markers Initiative.

Parkinsonism Relat Disord. 2019 Apr;61:118-125. doi: 10.1016/j.parkreldis.2018.11.006. Epub 2018 Dec 10.


Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review.

Sharma VD, Sengupta S, Chitnis S, Amara AW.

Front Neurol. 2018 Aug 27;9:697. doi: 10.3389/fneur.2018.00697. eCollection 2018. Review.


A feasibility study of combined intermittent theta burst stimulation and modified constraint-induced aphasia therapy in chronic post-stroke aphasia.

Szaflarski JP, Griffis J, Vannest J, Allendorfer JB, Nenert R, Amara AW, Sung V, Walker HC, Martin AN, Mark VW, Zhou X.

Restor Neurol Neurosci. 2018;36(4):503-518. doi: 10.3233/RNN-180812.


High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson's Disease.

Kelly NA, Wood KH, Allendorfer JB, Ford MP, Bickel CS, Marstrander J, Amara AW, Anthony T, Bamman MM, Skidmore FM.

Med Sci Monit. 2017 Dec 23;23:6064-6071.


Effects of Exercise on Non-motor Symptoms in Parkinson's Disease.

Amara AW, Memon AA.

Clin Ther. 2018 Jan;40(1):8-15. doi: 10.1016/j.clinthera.2017.11.004. Epub 2017 Dec 1.


Pedestrian safety in patients with Parkinson's disease: A case-control study.

Ford KJ, Joop A, Memon RA, Wood KH, Ball K, Cutter GR, Schwebel DC, Amara AW.

Mov Disord. 2017 Dec;32(12):1748-1755. doi: 10.1002/mds.27124. Epub 2017 Oct 4.


Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.

Amara AW, Walker HC, Joop A, Cutter G, DeWolfe JL, Harding SM, Standaert DG.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):183-190. doi: 10.1002/mdc3.12375. Epub 2016 Jun 6.


Treatment of Sleep Dysfunction in Parkinson's Disease.

Amara AW, Chahine LM, Videnovic A.

Curr Treat Options Neurol. 2017 Jul;19(7):26. doi: 10.1007/s11940-017-0461-6. Review.


Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.

Amara AW, Chahine LM, Caspell-Garcia C, Long JD, Coffey C, Högl B, Videnovic A, Iranzo A, Mayer G, Foldvary-Schaefer N, Postuma R, Oertel W, Lasch S, Marek K, Simuni T; Parkinson’s Progression Markers Initiative.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):653-662. doi: 10.1136/jnnp-2016-315023. Epub 2017 May 29.


The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.

Birchall EL, Walker HC, Cutter G, Guthrie S, Joop A, Memon RA, Watts RL, Standaert DG, Amara AW.

Brain Stimul. 2017 May - Jun;10(3):651-656. doi: 10.1016/j.brs.2016.12.014. Epub 2016 Dec 27.


A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Chahine LM, Amara AW, Videnovic A.

Sleep Med Rev. 2017 Oct;35:33-50. doi: 10.1016/j.smrv.2016.08.001. Epub 2016 Aug 31. Review.


The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.

Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M.

Mov Disord. 2016 Jun;31(6):924-32. doi: 10.1002/mds.26613. Epub 2016 Apr 26.


Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes.

Khawaja AM, Vines BL, Miller DW, Szaflarski JP, Amara AW.

Epileptic Disord. 2016 Mar;18(1):34-43. doi: 10.1684/epd.2016.0797.


Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K; PPMI Sleep Working group on behalf of the PPMI Investigators.

Mov Disord. 2015 Sep;30(10):1371-81. doi: 10.1002/mds.26248. Epub 2015 Jun 11.


Metabolomics and the search for biomarkers in Parkinson's disease.

Amara AW, Standaert DG.

Mov Disord. 2013 Oct;28(12):1620-1. doi: 10.1002/mds.25644. Epub 2013 Sep 18. No abstract available.


The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

Sung VW, Watts RL, Schrandt CJ, Guthrie S, Wang D, Amara AW, Guthrie BL, Walker HC.

J Neurosurg. 2013 Dec;119(6):1530-6. doi: 10.3171/2013.8.JNS122025. Epub 2013 Sep 27.


Challenges in diagnosis of isolated central nervous system vasculitis.

Amara AW, Bashir K, Palmer CA, Walker HC.

Brain Behav. 2011 Sep;1(1):57-61. doi: 10.1002/brb3.12.


Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease.

Amara AW, Standaert DG, Guthrie S, Cutter G, Watts RL, Walker HC.

Parkinsonism Relat Disord. 2012 Jan;18(1):63-8. doi: 10.1016/j.parkreldis.2011.09.001. Epub 2011 Sep 15.


The effects of deep brain stimulation on sleep in Parkinson's disease.

Amara AW, Watts RL, Walker HC.

Ther Adv Neurol Disord. 2011 Jan;4(1):15-24. doi: 10.1177/1756285610392446.

Supplemental Content

Loading ...
Support Center